Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 1 3

Status

Completed 291Terminated 51Recruiting 37Active not recruiting 26Unknown 23Withdrawn 21Not yet recruiting 4Suspended 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mesothelioma 1Lung Neoplasms 1Esophageal Neoplasms 1

Interventions

Specimen Handling 15Biopsy 9Cyclophosphamide 8Magnetic Resonance Spectroscopy 7venetoclax 5Etoposide 4Azacitidine 4fludarabine phosphate 3X-Rays 3Tacrolimus 3Paclitaxel 3Interleukin-2 3Carboplatin 3zanubrutinib 2prednylidene 2fludarabine 2durvalumab 2deltacortene 2aldesleukin 2Vincristine 2Rituximab 2Radiotherapy, Intensity-Modulated 2Protein Subunit Vaccines 2Prednisone 2Nivolumab 2Melphalan 2Injections 2Gemcitabine 2E 7107 2Doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Suspended × Paclitaxel × Clear all
NCT05191667 2025-02-13

AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Suspended
32 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT04711161 2024-01-23

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Green3Bio, Inc.

Phase 1 Suspended
73 enrolled
Gynecologic

Ovarian Neoplasms

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡